期刊文献+

左卡尼汀对急性心肌梗死大鼠TGF-β1表达的影响 被引量:6

Effect of Levocarnitine on the production of TGF-β1 in Acute Myocardial Infarction Rat
下载PDF
导出
摘要 目的探讨左卡尼汀对急性心肌梗死模型大鼠梗死区TGF-β1表达的影响。方法将通过结扎冠状动脉左前降支48只心梗模型鼠随机分成3组:心梗对照组(MI-C)、盐水对照组(MI-N,1 ml/d)、左卡尼汀治疗组(MI-L,40 mg/kg.d)。另设假手术组(MI-Sham)。同步药物干预2周后,ELISA法检测AngⅡ水平、RT-PCR检测梗死区TGF-β1 mR-NA。结果血清中AngⅡ的浓度:与假手术组比较,心梗对照组、盐水对照组、左卡尼汀治疗组均明显升高(P<0.05)。左卡尼汀治疗组、盐水对照组与心梗对照组水平接近,差异无显著性(P>0.05)。梗死区TGF-β1 mRNA的表达:与心梗对照组比较,左卡尼汀治疗组表达下调,差异具显著性(P<0.05);生理盐水对照组与心梗对照组水平接近,差异无显著性(P>0.05)。结论左卡尼汀能够明显地减少急性心肌梗死大鼠梗死区TGF-β1的表达水平。 Objective To study the effect of Levocarnitine on the expression of transforming growth factor-β1(TGF-β1) mRNA in acute myocardial infarction(AMI) rat.Methods We randomized 48 rats surviving left anterior descending coronary artery ligation to placebo(MI-control),isotonic saline solution(MIN,1ml/d) therapy and Levocarnitine(MI-L,40mg/kg.d) therapy with additional eight other rats being sham.Two weeks later,the level of plasma angiotensin Ⅱ(Ang Ⅱ) was detected using ELISA,and the expressions of TGF-β1 were measured by reverse transcription-polymerase chain reaction(RT-PCR).Results Plasma Ang Ⅱ concentration evidently raised in the MI-control rats,MI-saline rats and MI-Levocarnitine rats,compared with MI-sham rats.There was no significant difference between MI-saline rats and MI-Levocarnitine rats.The expressions of TGF-β1 were as follow: Compared with sham rats,the expressions of TGF-β1 of MI-control rats and the other two admission groups were significantly increased(P〈0.05).Compared with MI-control rats,the proteins were down-regulated in MI-Levocarnitine rats.There were no significant differences between MI-control rats and MI-saline rats(P〉0.05).Conclusion The Levocarnitine can significantly inhibit the production of TGF-β1 in case of non-interference of angiotensin.
出处 《中国实验诊断学》 北大核心 2011年第9期1444-1446,共3页 Chinese Journal of Laboratory Diagnosis
基金 国家自然科学基金资助项目(30770883)
关键词 急性心肌梗死 左卡尼汀 TGF-Β1 AngⅡ AMI Levocarnitine TGF-β1 Ang Ⅱ
  • 相关文献

参考文献1

二级参考文献18

  • 1庄海舟,沈潞华,刘冲.曲美他嗪对心力衰竭大鼠心功能自由基代谢心肌纤维化及心肌超微结构的影响[J].临床心血管病杂志,2006,22(9):541-544. 被引量:14
  • 2Tuo QH, Zeng H, Stinnett A, et al. Critical role of angiopoietins/Tie-2 in hyperglycemic exacerbation of myocardial infarction and impaired angiogenesis. Am J Physiol Heart Cire Physiol , 2008, 294 : 2547-2557.
  • 3Reed M J, Meszaros K, Entes LJ, et al. A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. Metabolism,2000, 49 : 1390-1394.
  • 4Filippo CD, Marfella R, Cuzzocrea S, et al. Hyperglycemia in streptozotocin-induced diabetic rat increases infarct size associated with low levels of myocardial HO-1 during ischemia/reperfusion.Diabetes, 2005, 54:803-810.
  • 5Talpur N, Echard B, Ingram C, et al. Effects of a novel formulation of essential oil on glucose-insulin metabolism in diabetic and hyperten- sive rats: a pilot study. Diabetes Obes Metah ,2005,7 : 193-199.
  • 6Wolff AA , Rotmensch HH , Stanley WC . Metabolic approaches to the treatment of ischemic heart disease : the clinicians' perspective. Heart Fail Rev ,2002,7 : 187-203.
  • 7Kantor PF , Lucien A, Kozak R. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondral long- chain3-ketoacyl coenzyme a thiolase. Circ Res, 2000,86 : 580- 588.
  • 8Cano C, Bermudez VJ, Medina MT, et al. Trimetazidine diminishes fasting glucose in rats with fasting hyperglycemia: a preliminary study. Am J, 2003,10:444-446.
  • 9Belardinelli R. Trimetazidine and the contractile response of dysfunctional myocardium in ischaemic cardiomyopathy. Rev Port Cardiol, 2000,19:35-39.
  • 10Morqan EE, Youngn ME, McElfresh TA, et al. Chronic treatment with trimetazidine reduces the upregulation of atrial natriuretic peptide in heart failure. Founda Clin phannacol , 2006,20 : 503- 505.

共引文献7

同被引文献81

引证文献6

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部